CLINICAL_TRIALS
trial_result
· 2016-02-26
Clinical Trial Update: Safety and Tolerability of MK-5478 in Participants With Hypertension (5478-001) [Phase 1]
Summary
Phase 1 trial update on safety and tolerability of MK-5478 in participants with hypertension; results completed with posted results in 2016.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Merck Sharp & Dohme LLC | Conditions: Hypertension | Phase 1 | Status: COMPLETED | Results posted: 2016-02-26